US electronic records: devices sector "not disadvantaged"
This article was originally published in Clinica
Executive Summary
Industry officials are relieved that the FDA's new draft guidance on the interpretation of Part 11 rules regarding electronic records does not contain a pharmaceutical bias that could be damaging to the devices industry.